Shots: Winlevi is a first-in-class topical androgen receptor inhibitor approved by the US FDA for the treatment of acne in patients (age ≥12 yrs.) with a new mechanism of action […]readmore
Tags : USFDA Approval
Shots: The approval is based on two clinical trials, a P-III study (n=15) and a P-I/IIa study (n=8) assessing Cystadrops at a median frequency of four times per day Result: […]readmore